MRNA
$25.09
Revenue | $142Mn |
Net Profits | $-825Mn |
Net Profit Margins | -580.99% |
Moderna, Inc.’s revenue fell -35.75% since last year same period to $142Mn in the Q2 2025. On a quarterly growth basis, Moderna, Inc. has generated 32.71% jump in its revenue since last 3-months.
Moderna, Inc.’s net profit jumped 35.5% since last year same period to $-825Mn in the Q2 2025. On a quarterly growth basis, Moderna, Inc. has generated 15.04% jump in its net profits since last 3-months.
Moderna, Inc.’s net profit margin fell -0.39% since last year same period to -580.99% in the Q2 2025. On a quarterly growth basis, Moderna, Inc. has generated 35.98% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -2.05 |
EPS Estimate Current Year | -2.05 |
Moderna, Inc.’s earning per share (EPS) estimates for the current quarter stand at -2.05 - a 31.21% jump from last quarter’s estimates.
Moderna, Inc.’s earning per share (EPS) estimates for the current year stand at -2.05.
Earning Per Share (EPS) | 0 |
Moderna, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Moderna, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-05-01 | -3.03 | -2.52 | 16.83% |
2025-10-30 | -2.05 | 0 | 100% |
2025-08-01 | -2.98 | -2.13 | 28.52% |